TITLE

Pediatric therapy protocols may improve outcome in adults with ALL

AUTHOR(S)
O'Brien, Susan M.
PUB. DATE
July 2008
SOURCE
Hem/Onc Today;7/25/2008, Vol. 9 Issue 13, p22
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses the findings of a study which examined the effect of pediatric therapy protocols on adult patients with acute lymphoblastic leukemia. The study, which was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting held from May 30 to June 3, 2008, included 225 patients who were assigned to five-drug induction, high-dose-intensity consolidation blocks, delayed intensification and two-year drug maintenance. It found that pediatric protocol is effective in patients aged 45 years and below.
ACCESSION #
33230004

 

Related Articles

  • Will the Pediatric Regimen Work for Adolescents With ALL? Carter, Andrea // JNCI: Journal of the National Cancer Institute;Sep2010, Vol. 102 Issue 17, p1308 

    The article discusses the application of pediatric regimen to adolescents with acute lymphoblastic leukemia (ALL). The author claims that various issues and barriers complicate treatments and outcomes. She reveals that young children with ALL have better prognosis and survival rates since they...

  • OSTRA BIAŁACZKA LIMFOBLASTYCZNA U DZIECI DIAGNOZOWANYCH I LECZONYCH W WOJEWÓDZKIM SPECJALISTYCZNYM SZPITALU DZIECIĘCYM W OLSZTYNIE W LATACH 1991-2007. Badowska, Wanda // Polish Annals of Medicine / Rocznik Medyczny;2008, Vol. 15 Issue 1, p145 

    Introduction. In the Province of Warmia and Mazury, population of 1.4 mln, 6-16 new cases of childhood leukaemia are notified annually. Aim. Analysis of the treatment results and prognostic factors in children with acute lymphoblastic leukaemia diagnosed and treated in Olsztyn between 1991 and...

  • Correlation of oral health of children with acute leukemia during the induction phase. Dholam, Kanchan P.; Gurav, Sandeep; Dugad, Jinesh; Banavli, Shripad // Indian Journal of Medical & Paediatric Oncology;Jan-Mar2014, Vol. 35 Issue 1, p36 

    Background: Treatment of acute leukemia's- a common childhood malignancy, involves intensive and powerful multi-drug chemotherapeutic regime. Oral lesions are a common complication in these patients affecting oral health status. Aim: This study was conducted to evaluate and assess the oral...

  • HISTIOCYTE RICH PSEUDOTUMOUR OF SPLEEN/SPLENIC LYMPH NODE AFTER CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA - A CASE REPORT. Rabia Ahmed; Ghafoor, Tariq; Akhtar, Farhan; Hashmi, Shoaib Naiyar; Hafeez-ud-Din; Jamal, Shahid // Pakistan Armed Forces Medical Journal;Mar2014, Vol. 64 Issue 1, p178 

    Post chemotherapy histiocyte-rich pseudotumour of spleen and lymph node are a rare occurrence and can be seen in patients after chemotherapy of haematological malignancies. We report the case of a two years old child, a diagnosed case of Acute Lymphoblastic Leukemia under going chemotherapy. He...

  • The treatment of acute leukemia: past, present, and future. Beutler, E // Leukemia (08876924);Apr2001, Vol. 15 Issue 4, p658 

    Presents information regarding the evolution of treatment for acute leukemia as of April 2001. Description of first case of leukemia in 1827; Treatment of first case of leukemia by using treatment protocols; Role of arsenic in the treatment of leukemia.

  • Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals. Pole, J. D.; Alibhai, S. M. H.; Ethier, M. C.; Teuffel, O.; Portwine, C.; Zelcer, S.; Johnston, D. L.; Silva, M.; Alexander, S.; Brandwein, J. M.; Sung, L. // Annals of Oncology;Mar2013, Vol. 24 Issue 3, p801 

    Background The objective was to compare 5-year overall survival (OS) between adolescent and young adult (AYA) patients (age 15–19) with acute lymphoblastic leukemia (ALL) treated at a pediatric versus an adult center. Patients and methods This was a population-based analysis using...

  • Leucémies aiguës lymphoblastiques de l’enfant. Bertrand, Y. // Oncologie;jui2006, Vol. 8 Issue 6, p529 

    The cure rate of children with acute lymphoblastic leukemia (ALL) approaches 80%. Numerous prognostic factors based on clinical, biological and therapeutic data have been identified. Prognostic factors of childhood ALL include: age, white blood cell count, cytogenetics, and early response to...

  • Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994. Maloney, K W; Shuster, J J; Murphy, S; Pullen, J; Camitta, B A // Leukemia (08876924);Dec2000, Vol. 14 Issue 12, p2276 

    This paper presents the long-term results of treatment for children with acute lymphoblastic leukemia (ALL) as conducted by the Pediatric Oncology Group (POG) from 1986 to 1994. The data are presented using standard NCI/Rome risk criteria. The overall event-free survival (EFS) at 5 and 10 years...

  • Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Gaynon, P S; Trigg, M E; Heerema, N A; Sensel, M G; Sather, H N; Hammond, G D; Bleyer, W A // Leukemia (08876924);Dec2000, Vol. 14 Issue 12, p2223 

    Since 1968, the Children's Cancer Group (CCG) has treated more than 16 000 children with acute lymphoblastic leukemia (ALL). Herein, we report improvements obtained in CCG trials during two successive series of studies (1983-1988 and 1989-1995). Overall, 10-year EFS was 62% &plusmin; 10% for the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics